Pfizer tops earnings estimates as Covid product sales beat expectations and cost cuts pay off

Albert Bourla, chairman and CEO of Pfizer, speaks at The Wall Street Journal’s Future of Everything Festival in New York City, U.S., May 22, 2024.Pfizer on Tuesday reported fourth-quarter earnings and revenue that beat estimates as sales of the company's Covid products topped expectations and cancer drugs from its acquisition of Seagen boosted revenue.Here's what the company reported for the fourth quarter compared with what Wall Street was expecting, based on a survey of analysts by LSEG: Earnings per shar ...